The table contains 12 products whose active ingredient are classified under the same pharmacologic class Decreased GnRH Secretion [PE].
|
NDC |
Proprietary Name |
Non-Proprietary Name |
Dosage Form |
Route Name |
Company Name |
Status |
| 0074-0038 | Orilissa | Non-Proprietary Name: Elagolix | Tablet, Film Coated | Oral | Abbvie Inc. | ACTIVE |
| 0074-0039 | Orilissa | Non-Proprietary Name: Elagolix | Tablet, Film Coated | Oral | Abbvie Inc. | ACTIVE |
| 0548-5001 | Ganirelix Acetate | Non-Proprietary Name: Ganirelix Acetate | Injection | Subcutaneous | Amphastar Pharmaceuticals, Inc. | ACTIVE |
| 55566-1010 | Fyremadel | Non-Proprietary Name: Ganirelix Acetate | Injection, Solution | Subcutaneous | Ferring Pharmaceuticals Inc. | ACTIVE |
| 65219-028 | Ganirelix Acetate | Non-Proprietary Name: Ganirelix Acetate | Injection | Subcutaneous | Fresenius Kabi Usa, Llc | ACTIVE |
| 68083-472 | Ganirelix Acetate | Non-Proprietary Name: Ganirelix Acetate | Injection, Solution | Subcutaneous | Gland Pharma Limited | ACTIVE |
| 70700-327 | Ganirelix Acetate | Non-Proprietary Name: Ganirelix Acetate | Injection | Subcutaneous | Xiromed Llc | ACTIVE |
| 70748-274 | Ganirelix Acetate | Non-Proprietary Name: Ganirelix Acetate | Injection, Solution | Subcutaneous | Lupin Pharmaceuticals, Inc. | ACTIVE |
| 71288-554 | Ganirelix Acetate | Non-Proprietary Name: Ganirelix Acetate | Injection, Solution | Subcutaneous | Meitheal Pharmaceuticals Inc. | ACTIVE |
| 72974-120 | | Non-Proprietary Name: Relugolix | Tablet, Film Coated | | Sumitomo Pharma America, Inc. | ACTIVE |
| 72974-120 | Orgovyx | Non-Proprietary Name: Relugolix | Tablet, Film Coated | Oral | Sumitomo Pharma America, Inc | ACTIVE |
| 72974-415 | Myfembree | Non-Proprietary Name: Relugolix, Estradiol Hemihydrate, And Norethindrone Acetate | Tablet, Film Coated | Oral | Sumitomo Pharma America, Inc | ACTIVE |
| 78206-138 | Ganirelix Acetate | Non-Proprietary Name: Ganirelix Acetate | Injection, Solution | Subcutaneous | Organon Llc | ACTIVE |